Biotechnology News

March 26, 2012

SILVER SPRING, Md.--(BUSINESS WIRE)--Nuvilex, Inc. (OTCQB:NVLX) and associate SG Austria announced a new, unique, and specialized encapsulated cell gene expression induction system.

March 26, 2012

EXTON, Pa.--(BUSINESS WIRE)--Following the loss of patent exclusivity in late 2011, Pfizer’s Xalatan has lost three-quarters of its share to generic latanoprost.

March 26, 2012

MISGAV, Israel & SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue,...

March 26, 2012

SAN DIEGO--(BUSINESS WIRE)--Illumina, Inc. (NASDAQ:ILMN), a leading developer, manufacturer, and marketer of life science tools and integrated systems for the analysis of genetic variation and function, today sent a second letter to its...

March 26, 2012

CHICAGO & SANTA BARBARA, Calif.--(BUSINESS WIRE)--MarketMonitors, Inc. (MMI), a provider of online business intelligence and analytic databases, announced today the international launch of its new Drug-Resistant Hypertension (HTN) sector for...

March 26, 2012

SAN DIEGO--(BUSINESS WIRE)--At the American Chemical Society’s Spring 2012 National Meeting & Expo, PerkinElmer, Inc., a global leader focused on improving the health and safety of people and the environment, today announced the launch of its...

March 26, 2012

SAN FRANCISCO--(BUSINESS WIRE)--Cook Medical is pleased to announce the introduction of two bone biopsy products, the Osteo-Site® Ratchet™ and the Osteo-Site® coaxial bone biopsy needle set.

March 26, 2012

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. announced today that the U.S. Food and Drug Administration (FDA) has approved QNASLTM Nasal Aerosol, a new, “dry” nasal aerosol corticosteroid that treats seasonal nasal and year-...

March 26, 2012

MONTREAL--(BUSINESS WIRE)--Sunshine Biopharma, Inc. (OTCBB: SBFM), which has designed and synthesized a new compound, Adva-27a, that acts as an inhibitor of multidrug resistant breast cancer cells in vitro, today announced that it will be...

March 26, 2012

LOS ANGELES--(BUSINESS WIRE)--Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and commercialization of molecular diagnostic tests for cancer, announced today the addition of Stephanie H. Astrow, Ph.D., as the Company’s...

March 26, 2012

NEW YORK--(BUSINESS WIRE)--Pfizer Oncology will present data from a variety of preclinical and clinical studies of Pfizer’s early-stage compounds, including data from Pfizer’s investigational antibody-drug conjugate (ADC) portfolio and research...

March 26, 2012

CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced its schedule of preclinical data presentations to be made at the American Association for Cancer Research (AACR) Annual Meeting 2012, taking place...

March 26, 2012

DUBLIN--(BUSINESS WIRE)--Covidien plc (NYSE: COV) will report second-quarter results on April 27, 2012, before trading begins. The Company will hold a conference call for investors at 8:30 a.m. ET. The call can be accessed in the following ways:...

March 26, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the diagnosis and treatment of neurological complications of diabetes announced that Chief Executive Officer Shai N. Gozani, M.D., Ph.D. has...

March 26, 2012

DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets (http://www.researchandmarkets....

March 26, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology, Inc. announced today that it has reached the target enrollment in its pivotal LEAP (Low hENT1 and Adenocarcinoma of the Pancreas) study of CO-101 in metastatic pancreatic cancer.

March 26, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: Today Vitrolife (STO:VITR) is publishing the Annual Report for 2011 in Swedish. The Annual Report is attached to this press release and will also be available on...

March 26, 2012

NEW YORK & LAUSANNE, Switzerland & LONDON--(BUSINESS WIRE)--Celtic Therapeutics Management, a private equity firm focused on novel therapeutics, launches Swiss based company: ADC Therapeutics with 10 ADC oncology development programs...

March 26, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC: Michael J. Fox Foundation Invests $179 Million in the Fight Against Parkinson’s Disease

March 26, 2012

NEWARK, Del.--(BUSINESS WIRE)--New technologies to produce vaccines more safely, quickly and economically than traditional approaches are featured at the New Cells, New Vaccines VI: Target to Market international scientific conference, currently...

March 26, 2012

TOKYO & NEW YORK--(BUSINESS WIRE)--Asahi Kasei Corporation (TSE1: 3407, hereinafter: Asahi Kasei), Japan's leading diversified chemical manufacturer with businesses in the health care, chemicals & fibers, homes & construction...

March 26, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE: AZN) today announced that on March 23, 2012 the US District Court for the District of Columbia issued an opinion and order in AstraZeneca’s lawsuit against the US Food and Drug Administration...

March 26, 2012

BASEL, Switzerland--(BUSINESS WIRE)--Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it has extended its cash tender offer to acquire all outstanding shares of Illumina, Inc. (NASDAQ: ILMN), at a price of $44.50 per share, to 6:00 p.m.,...

March 25, 2012

CHICAGO--(BUSINESS WIRE)--Theracurmin, an absorption-enhanced form of curcumin, developed by Theravalues Corporation, a Japanese bio-venture, is affirmed to be beneficial on diastolic function in hypertensive patients.

March 25, 2012

MINNEAPOLIS & CHICAGO--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT), announced that the Symplicity™ renal denervation system provides safe, significant and sustained blood pressure reduction up to three years in patients with treatment-...

March 25, 2012

CHICAGO--(BUSINESS WIRE)--AstraZeneca (NYSE: AZN) today announced results from a sub-analysis of the PLATO genetic sub-study that evaluated the impact of poor metabolizers of clopidogrel. Data suggests results were consistent with the overall...

March 24, 2012

CHICAGO--(BUSINESS WIRE)--According to new clinical data presented today at ACC.12 –– the 61st Annual Scientific Session & Expo of the American College of Cardiology (ACC) –– the Resolute drug-eluting stent (DES) from Medtronic, Inc. (NYSE:...

March 24, 2012

ST. PAUL, Minn. & CHICAGO--(BUSINESS WIRE)--Cardiovascular Systems presented 12-month data from the COMPLIANCE 360° study of severely calcified above-the-knee lesions at the American College of Cardiology’s 61st Annual Scientific Session.

March 23, 2012

SAN DIEGO--(BUSINESS WIRE)--PerkinElmer Launches Innovative Informatics Solutions at the American Chemical Society Spring 2012 National Meeting & Expo

March 23, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer Partnered with Journeys Within Our Communities to provide access to clean drinking water for 1,000 people in Cambodia

March 23, 2012

ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical announces key findings at ACC.12 – the 61st Annual Scientific Session and Expo of the American College of Cardiology.

March 23, 2012

BOSTON--(BUSINESS WIRE)--The second annual conference of the Pistoia Alliance on April 24, 2012, will feature several deliverables for NGS data management and analysis developed through precompetitive collaboration.

March 23, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Repligen Corporation (NASDAQ:RGEN) today announced that the U.S. Food and Drug Administration’s Gastrointestinal Drugs Advisory Committee will meet on May 31, 2012 to discuss the Company’s New Drug Application (...

March 23, 2012

NATICK, Mass.--(BUSINESS WIRE)--Corindus Vascular Robotics announced that data and acute results from its CorPath PRECISE Trial will be presented during a scientific presentation at ACC 2012.

March 23, 2012

MISGAV, Israel and SAN FRANCISCO--(BUSINESS WIRE)--Medgenics, Inc. (NYSE Amex: MDGN and AIM: MEDU, MEDG), the developer of a novel technology for the sustained production and delivery of therapeutic proteins in patients using their own tissue,...

March 23, 2012

KNOXVILLE, Tenn.--(BUSINESS WIRE)--Mechanism of action data presented at the Society of Surgical Oncology Annual Meeting confirms that PV-10 therapy induces an immunologic response.

March 23, 2012

HORSHAM, Pa.--(BUSINESS WIRE)--ImpactRx, a Symphony Technology Group (STG) company, announced today that it has acquired AlphaDetail, Inc., a leader in global healthcare primary market research and influence network mapping.

March 23, 2012

NOKOMIS, Fla.--(BUSINESS WIRE)--RBCC Prepares to Join the $3 Billion Fight Against Parkinson’s Disease

March 23, 2012

NEWTOWN, Pa.--(BUSINESS WIRE)--BioClinica announces its partnership with NextDocs to deliver solutions that provide easier access to clinical trial information and decrease the timeline for FDA submissions.

March 23, 2012

BOULDER, Colo.--(BUSINESS WIRE)--Clovis Oncology announced today that it has filed a registration statement on Form S-1 with the SEC relating to a proposed underwritten public offering of $75 million of shares of its common stock

March 23, 2012

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: The Annual General Meeting will be held at 4 p.m. on Tuesday April 24, 2012, at Precise Biometrics (STO:PREC) premises, Scheelevägen 30 in Lund, Sweden. An agenda containing the matters that are...

March 23, 2012

GÖTEBORG, Sweden--(BUSINESS WIRE)--Regulatory News: The Nomination Committee of Meda AB (STO:MEDAA) proposes the election of Lars Westerberg as new board member. The committee also proposes re-election of Maria Carell, Peter Claesson, Peter von...

March 23, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Hyperion Therapeutics, Inc. today announced that it has acquired worldwide rights to the investigational drug Ravicti™ (glycerol phenylbutyrate) from Ucyclyd Pharma, Inc., a wholly owned subsidiary of...

March 23, 2012

NEWTON, Mass.--(BUSINESS WIRE)--Galectin Therapeutics announces pricing of public offering and listing on NASDAQ.

March 22, 2012

ROCKVILLE, Md.--(BUSINESS WIRE)--Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has received a multi-year grant from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, to...

March 22, 2012

WILMINGTON, Mass.--(BUSINESS WIRE)--Accellent Inc. (the “Company” or “Accellent”), a wholly owned subsidiary of Accellent Holdings Corp., today announced results for its fiscal fourth quarter ended December 31, 2011. Fourth Quarter 2011 Financial...

March 22, 2012

NEWARK, Del.--(BUSINESS WIRE)--SDIX (Nasdaq: SDIX), a leading provider of biotechnology-based products and services for a broad range of life science, biotechnology, diagnostic and food safety applications, today reported financial results for...